Head, Div of Digestive Diseases, Hepatology and Nutrition Professor of Pediatrics
Pediatric Gastroenterology
Dr. Jeffrey S. Hyams, MD
|
|
Give Review
Jeffrey Hyams practices Pediatric Gastroenterology. He went to Perelman School of Medicine at the University of Pennsylvania. He received 1 awards: "Regional Top Doctor". Jeffrey Hyams is a published physician. He has 42 publications published. The most current publication "Well-Defined and Reliable Clinical Outcome Assessments for Pediatric Crohn's Disease: A Critical Need for Drug Development."
Publications
- Pharmacokinetics and exposure-efficacy relationship of adalimumab in pediatric patients with moderate to severe Crohn's Disease: results from a randomized, multicenter...
- Well-Defined and Reliable Clinical Outcome Assessments for Pediatric Crohn's Disease: A Critical Need for Drug Development.
- Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's Disease.
- Can early anti-TNF-α treatment be an effective therapeutic strategy in children with Crohn's Disease?
- Utility of Neutrophil Fcγ Receptor I (CD64) Index as a Biomarker for Mucosal Inflammation in Pediatric Crohn's Disease.
- Pediatric UC Drug Development: A GREAT Idea Now Needs a GRAND Conversation.
- The treatment-naive microbiome in new-onset Crohn's Disease.
- Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's Disease.
- Transition of management in adolescents with IBD.
- Pharmacokinetics of Infliximab in Children with Moderate-to-Severe Ulcerative Colitis: Results from a Randomized, Multicenter, Open-label, Phase 3 Study.
- Fecal transplantation: re-discovering the value of stool.
- Extraintestinal hodgkin Disease in a young man with crohn Disease treated with multiple immunosuppresive therapies.
- Challenges in IBD Research: Update on Progress and Prioritization of the CCFA's Research Agenda.
- Safety and efficacy of adalimumab for moderate to severe Crohn's Disease in children.
- Outcome Following Aminosalicylate Therapy In Children Newly Diagnosed With Ulcerative Colitis: A Prospective Multi-Center Registry Experience.
- Induction and maintenance therapy with infliximab for children with moderate to severe Ulcerative colitis.
- Fecal osteoprotegerin may guide the introduction of second-line therapy in hospitalized children with Ulcerative colitis.
- Pediatric modification of the Montreal classification for inflammatory bowel Disease: The Paris classification.
- Outcome following thiopurine use in children with Ulcerative colitis: a prospective multicenter registry study.
- Consensus for Managing Acute Severe Ulcerative Colitis in Children: A Systematic Review and Joint Statement From ECCO, ESPGHAN, and the Porto IBD Working Group of ESPG...
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and...
- Real-time tool to display the predicted Disease course and treatment response for children with Crohn's Disease.
- Factors that determine risk for surgery in pediatric patients with Crohn's Disease.
- Extraintestinal manifestations of pediatric inflammatory bowel Disease and their relation to Disease type and severity.
- Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's Disease.
- A two-year longitudinal study of persistent lean tissue deficits in children with Crohn's Disease.
- Course and treatment of perianal Disease in children newly diagnosed with Crohn's Disease.
- Organization of a research consortium: the time is now.
- Diagnosis and management of inflammatory bowel Disease in children.
- Natural history of bone metabolism and bone mineral density in children with inflammatory bowel Disease.
- Are activated T cells regulators of bone metabolism in children with Crohn Disease?
- Childhood functional Gastrointestinal disorders: child/adolescent.
- Treatment of functional gastrointestinal disorders associated with Abdominal pain.
- Can we alter the natural history of Crohn Disease in children?
- Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's Disease: pro.
- Irritable bowel syndrome, functional dyspepsia, and functional Abdominal pain syndrome.
- Infliximab treatment of Crohn's Disease in children: it's time to not go retro(spective).
- Diet and gastrointestinal Disease.
- Effect of Crohn's Disease on bone metabolism in vitro: a role for interleukin-6.
- Recurrent Abdominal pain in children.
- Standardized recording of parameters related to the natural history of inflammatory bowel Disease: from montreal to paris.
Schools
University Of Pennsylvania School Of Medicine
Chldns Hospital Med Center
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Liver Biopsy
Conditions Treated
- Abdominal Pain
- Anemia
- Benign Neoplasm of the Digestive System
- Biliary Atresia
- View All
Doctors Specialties
- Pediatric Gastroenterology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Boston Children's Hospital -
Perelman School of Medicine at the University of Pennsylvania
Helpful Reviews
Similar Doctors
|
|
Dr. Bella Zeisler, MD |
|
|
Dr. Karan M. Emerick, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francisco A. Sylvester, MD |
|
|
Dr. Donna Zeiter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessica E. Stumphy, MD |
|
|
Dr. Ajay K. Rana, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Einar T. Hafberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Franziska Mohr, MD |